Participants
Participants at the ECNP Summit on the future of CNS drug research in Europe, Nice, France.
Faculty
Pharmaceutical Companies
Related Organisations
Patient groups
Additional Participants
Faculty (in alphabetic order of last name)
Celso Arango
Professor of Psychiatry
Hospital General Universitario Gregorio Marañón, Madrid, Spain
ECNP Network Initiative Child and Adolescent Neuropsychopharmacology
ECNP Executive Committee
Patrice Boyer
Professor of Psychiatry
Université Paris Diderot, France
President European Psychiatric Association
Adam Cohen
Chief Executive Officer
Centre for Human Drug Research, Leiden, The Netherlands
Philippe Cupers
Sector Head Neuroscience, Health Directorate
EU Directorate General for Research and Innovation
Christine Gispen-de Wied
Member, CNS Working Party (CNSWP) and Scientific Advice Working Party (SAWP)
European Medicines Agency
Guy Goodwin
Professor of Psychiatry
University of Oxford, United Kingdom
President-Elect ECNP
Co-organiser ECNP Summit
Thomas R. Insel
Director
National Institute of Mental Health, United States
Maria Isaac
Scientific Advice Section
European Medicines Agency
Bengt Jönsson
Professor of Health Economics
Stockholm School of Economics, Sweden
Shitij Kapur
Dean and Head of School
Institute of Psychiatry, King’s College London, United Kingdom
Thomas Lönngren
Former Executive Director, European Medicines Agency
Strategic Advisor, NDA Group, United Kingdom
Jeffrey S. Nye
Vice President and Global Head, External Innovation, Neuroscience Franchise
Johnson & Johnson
David Nutt
Professor of Neuropsychopharmacology
Imperial College London, United Kingdom
ECNP Past-President
ECNP Summit Co-organiser
Atul C. Pande
Senior Vice President, Neuroscience MDC Head
GlaxoSmithKline
Anders G. Pedersen
Executive Vice President Drug Research
Lundbeck A/S
Sven Schellberg
Director, Global Medical Leader
Actelion Pharmaceuticals Ltd.
Hans-Ulrich Wittchen
Director and Chairman
Institute of Clinical Psychology and Psychotherapy
Dresden Technical University, Germany
ECNP Vice-President
Joseph Zohar
Professor of Psychiatry
Tel Aviv University, Israel
President ECNP
Barbara van Zwieten-Boot
Chair CNS Working Party (CNSWP), Member Committee for Medicinal Products for Human Use (CHMP)
European Medicines Agency
Pharmaceutical Companies (in alphabetic order)
Abbott |
Hans Schoemaker, Head CNS Research Germany
|
Actelion |
Sven Schellberg (see faculty)
|
Addex Pharmaceuticals |
Vincent Mutel, Chief Executive Officer
|
AstraZeneca |
Christer Köhler, Global Vice-President Discovery Research
|
BMS |
Sieglinde Modell, Medical Director Neuroscience
|
GSK |
Atul C. Pande (see faculty)
|
Johnson & Johnson |
Jeffrey S. Nye (see faculty)
|
Eli Lilly |
Mark Tricklebank, Director, Senior Research Fellow
|
Lundbeck |
Anders Gersel Pedersen (see faculty)
|
Novartis |
Graeme Bilbe, Global Head of Neuroscience Research
|
P1vital
|
Gerry Dawson, Chief Scientific Officer
|
Pfizer |
Philip Ninan, Vice-President and Global Clinical Lead, Clinical Disease Area Expert - Psychiatry Clinical Sciences
|
Roche |
Luca Santarelli, Head of CNS Discovery and Translational Area
|
Servier |
Emmanuele Canet, President Research and Development |
Related Organisations (in alphabetic order)
Association for the Improvement of Mental Health Programmes (AIMHP)
Norman Sartorius, President
American Psychiatric Association (APA), American College of Neuropsychopharmacology (ACNP), Society of Biological Psychiatry (SOBP)
Alan F. Schatzberg
International College of Neuro-Psychopharmacology (CINP)
Robert H. Belmaker, Past President
European Brain Council (EBC)
Mary G. Baker, President
Julien Mendlewicz, Past President
Alastair Benbow, Executive Director
European Federation of Neurological Associations (EFNA)
Mary G. Baker, President
European Federation of Neurological Societies (EFNS)
Gian Luigi Lenzi, Vice President
European Medicines Agency (EMA)
Fernando de Andrés Trelles, Member Scientific Advice Working Party (SAWP), CNS Working Party (CNSWP) and Paediatric Committee (PDCO)
Manuel Haas, Head of Section CNS and Ophthalmology (Safety and Efficacy)
Luca Pani, Member CNS Working Party (CNSWP)
European Psychiatric Association (EPA)
Patrice Boyer (see faculty)
World Federation of Societies of Biological Psychiatry (WFSBP)
Florence Thibaut, President
Patient groups (in alphabetic order)
British Medical Journal’s Patient Advisory Group
Mary G. Baker, Chair
European Federation of Associations of Families of People with Mental Illness (EUFAMI)
Kevin Jones, Secretary General
Global Alliance of Mental Illness Advocacy Networks (GAMIAN)
Dolores Gauci, President
Additional Participants (in alphabetic order of last name)
David Baldwin, United Kingdom
ECNP Consultation Meeting Committee
Michael Davidson, Israel
ECNP Consultation Meeting Committee
Editor-in-Chief European Neuropsychopharmacology
Michel Hamon, France
Chair ECNP Scientific Programme Committee
Jaanus Harro, Estonia
ECNP Executive Committee
Gitte M. Knudsen, Denmark
ECNP Executive Committee
Mark Millan, France
ECNP Executive Committee
Sven Ove Ögren, Sweden
ECNP Secretary
Alexander Schubert
ECNP Executive Director
Wim van den Brink, The Netherlands
ECNP Executive Committee
Eduard Vieta, Spain
ECNP Executive Committee
Maria Vrijmoed-de Vries
Manager Science, Education and Communication
ECNP Office
Related pages / downloads
Programme